Literature DB >> 21937663

DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein Apoptin.

Thomas J Kucharski1, Isabelle Gamache, Ole Gjoerup, Jose G Teodoro.   

Abstract

The chicken anemia virus (CAV) protein Apoptin is a small, 13.6-kDa protein that has the intriguing activity of inducing G(2)/M arrest and apoptosis specifically in cancer cells by a mechanism that is independent of p53. The activity of Apoptin is regulated at the level of localization. Whereas Apoptin is cytoplasmic in primary cells and does not affect cell growth, in transformed cells it localizes to the nucleus, where it induces apoptosis. The properties of cancer cells that are responsible for activating the proapoptotic activities of Apoptin remain unclear. In the current study, we show that DNA damage response (DDR) signaling is required to induce Apoptin nuclear localization in primary cells. Induction of DNA damage in combination with Apoptin expression was able to induce apoptosis in primary cells. Conversely, chemical or RNA interference (RNAi) inhibition of DDR signaling by ATM and DNA-dependent protein kinase (DNA-PK) was sufficient to cause Apoptin to localize in the cytoplasm of transformed cells. Furthermore, the nucleocytoplasmic shuttling activity of Apoptin is required for DDR-induced changes in localization. Interestingly, nuclear localization of Apoptin in primary cells was able to inhibit the formation of DNA damage foci containing 53BP1. Apoptin has been shown to bind and inhibit the anaphase-promoting complex/cyclosome (APC/C). We observe that Apoptin is able to inhibit formation of DNA damage foci by targeting the APC/C-associated factor MDC1 for degradation. We suggest that these results may point to a novel mechanism of DDR inhibition during viral infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937663      PMCID: PMC3209404          DOI: 10.1128/JVI.05009-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Apoptin's functional N- and C-termini independently bind DNA.

Authors:  S R Leliveld; R T Dame; J L Rohn; M H M Noteborn; J P Abrahams
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

2.  Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity.

Authors:  Yen-Hsien Lee; Chih-Mei Cheng; Yung-Fu Chang; Ting-Yi Wang; Chung-Yee Yuo
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

3.  Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells.

Authors:  A A Danen-Van Oorschot; D F Fischer; J M Grimbergen; B Klein; S Zhuang; J H Falkenburg; C Backendorf; P H Quax; A J Van der Eb; M H Noteborn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes.

Authors:  Yukitaka Shizukuda; Mary E Reyland; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

Review 7.  The anaphase promoting complex: a critical target for viral proteins and anti-cancer drugs.

Authors:  Destin W Heilman; Michael R Green; Jose G Teodoro
Journal:  Cell Cycle       Date:  2005-04-16       Impact factor: 4.534

8.  Partial deficiency of DNA-PKcs increases ionizing radiation-induced mutagenesis and telomere instability in human cells.

Authors:  Ying Zhang; Junqing Zhou; Xiaofan Cao; Qinming Zhang; Chang U K Lim; Robert L Ullrich; Susan M Bailey; Howard L Liber
Journal:  Cancer Lett       Date:  2006-11-13       Impact factor: 8.679

9.  MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Xianglin Wu; Junjie Chen
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

10.  Surveillance mechanism linking Bub1 loss to the p53 pathway.

Authors:  Ole V Gjoerup; Jiaping Wu; Devin Chandler-Militello; Grace L Williams; Jean Zhao; Brian Schaffhausen; Parmjit S Jat; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

View more
  17 in total

1.  Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC.

Authors:  Xuan Han; Peng Ren; Shaohua Ma
Journal:  Open Med (Wars)       Date:  2022-07-06

2.  Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral Replication.

Authors:  Thomas J Kucharski; Timothy F Ng; David M Sharon; Pedram Navid-Azarbaijani; Mahvash Tavassoli; Jose G Teodoro
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing.

Authors:  R Zimmerman; D J Peng; H Lanz; Y H Zhang; A Danen-Van Oorschot; S Qu; C Backendorf; M Noteborn
Journal:  Cell Death Dis       Date:  2012-04-05       Impact factor: 8.469

4.  Human gyrovirus DNA in human blood, Italy.

Authors:  Fabrizio Maggi; Lisa Macera; Daniele Focosi; Maria Linda Vatteroni; Ugo Boggi; Guido Antonelli; Marc Eloit; Mauro Pistello
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

Review 5.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

6.  Enhanced tumour cell nuclear targeting in a tumour progression model.

Authors:  Michael S Nastasie; Helmut Thissen; David A Jans; Kylie M Wagstaff
Journal:  BMC Cancer       Date:  2015-02-21       Impact factor: 4.430

7.  Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.

Authors:  Rachid Zagani; Wissal El-Assaad; Isabelle Gamache; Jose G Teodoro
Journal:  Oncotarget       Date:  2015-09-29

8.  p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells.

Authors:  Dan Xu; Qian Du; Cong Han; Zengguo Wang; Xiujuan Zhang; Tongtong Wang; Xiaomin Zhao; Yong Huang; Dewen Tong
Journal:  Vet Res       Date:  2016-11-29       Impact factor: 3.683

Review 9.  Viral Proteins as Emerging Cancer Therapeutics.

Authors:  Ekta Manocha; Arnaldo Caruso; Francesca Caccuri
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

10.  Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin.

Authors:  H L Lanz; R M E Zimmerman; J Brouwer; M H M Noteborn; C Backendorf
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.